DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Nitric oxide synthase inhibitor - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Nitric oxide synthase inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 5+ companies and...
January 2022
60 pages
NK Cell therapies - Pipeline Insight, 2022
US$ 3,000.00
This report can be delivered to the clients within 90 hours DelveInsight’s, “NK Cell therapy - Pipeline Insight, 2022” report provides comprehensive insights about 80+ companies and 100+ pipeline dr...
January 2022
120 pages
NLRP3 protein inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “NLRP3 protein inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companies an...
January 2022
60 pages
NMDA receptor antagonists - Pipeline Insight, 2022
US$ 2,000.00
This report can be delivered to the clients within 72 hours DelveInsight’s, “NMDA Receptor Antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 25+ companies and 25+ pi...
January 2022
120 pages
Nociceptin receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Nociceptin receptor agonists - Pipeline Insight, 2022” report provides comprehensive insights about 12+ companie...
January 2022
60 pages
Nonmelanoma Skin Cancer- Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Nonmelanoma Skin Cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Noonan Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Noonan Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Notch receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Notch receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pip...
January 2022
60 pages
Ocular GvHD - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ocular GvHD - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Ocular Hypertension - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ocular Hypertension - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hi...
January 2022
60 pages
Ocular pain - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ocular pain - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Oncocytoma - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Oncocytoma - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Oncolytic Adenovirus - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Oncolytic Adenovirus - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, h...
January 2022
60 pages
Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022
US$ 2,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Oncolytic Virus Cancer Therapy - Pipeline Insight, 2022” report provides comprehensive insights about 45+ compan...
January 2022
140 pages
Onycholysis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Onycholysis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical...
January 2022
60 pages
Ophthalmoplegia - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ophthalmoplegia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Opioid Dependence - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Opioid Dependence - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Opioid kappa receptor agonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Opioid Kappa Receptor Agonists - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies and 1...
January 2022
60 pages
Opioid mu receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Opioid mu receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies and 1...
January 2022
60 pages
Opioid Overdose - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Opioid Overdose - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
